Jessica Vermeulen Selected Research

Jessica Vermeulen Research Topics

Disease

10	Multiple Myeloma 04/2023 - 01/2019
10	Neoplasms (Cancer) 04/2023 - 09/2011
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 08/2014
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2022 - 02/2016
4	Amyloidosis 11/2022 - 01/2021
4	Lymphopenia (Lymphocytopenia) 11/2021 - 10/2015
3	Immunoglobulin Light-chain Amyloidosis 12/2023 - 01/2020
3	Pneumonia (Pneumonitis) 11/2021 - 01/2021
3	Neutropenia 11/2021 - 01/2021
3	Multi-centric Castleman's Disease 11/2017 - 08/2014
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2015 - 08/2014
2	Lymphoma (Lymphomas) 01/2023 - 12/2017
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2022 - 10/2018
2	Disease Progression 10/2021 - 01/2021
2	Hypertension (High Blood Pressure) 10/2021 - 10/2018
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021 - 08/2014
2	Diarrhea 01/2021 - 10/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018 - 10/2017
2	Atrial Fibrillation 10/2018 - 10/2017
2	Rheumatoid Arthritis 11/2017 - 10/2015
2	Castleman Disease (Castleman's Disease) 10/2015 - 10/2015
1	Rare Diseases (Rare Disease) 12/2023
1	Thrombosis (Thrombus) 11/2022
1	Septic Shock (Toxic Shock Syndrome) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Heart Failure 01/2021
1	Inflammation (Inflammations) 01/2021
1	Anhedonia 11/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2017
1	Major Depressive Disorder (Major Depressive Disorders) 11/2017
1	Leukopenia 10/2015
1	Infections 10/2015
1	Hypertriglyceridemia 10/2015
1	Hypercholesterolemia 10/2015
1	Polycythemia (Erythrocytosis) 10/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2015
1	Anemia 10/2015
1	Fatigue 04/2015
1	Chronic Disease (Chronic Diseases) 04/2015
1	Pain (Aches) 04/2015
1	Sepsis (Septicemia) 08/2014
1	Anaphylaxis (Anaphylactic Shock) 08/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2014
1	Ovarian Neoplasms (Ovarian Cancer) 09/2011

Drug/Important Bio-Agent (IBA)

13	ibrutinibIBA 11/2022 - 08/2014
12	daratumumabIBA 04/2023 - 01/2019
12	Dexamethasone (Maxidex)FDA LinkGeneric 04/2023 - 01/2019
10	Bortezomib (Velcade)FDA Link 11/2022 - 01/2019
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 08/2014
7	Interleukin-6 (Interleukin 6)IBA 11/2017 - 09/2011
6	Lenalidomide (CC 5013)FDA Link 04/2023 - 01/2020
6	siltuximabIBA 10/2015 - 09/2011
5	Rituximab (Mabthera)FDA Link 11/2022 - 08/2014
5	Monoclonal AntibodiesIBA 11/2017 - 04/2014
4	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2021
4	Prednisone (Sone)FDA LinkGeneric 11/2022 - 08/2014
4	Vincristine (Oncovin)FDA LinkGeneric 11/2022 - 08/2014
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2022 - 08/2014
3	temsirolimus FDA Link 10/2022 - 02/2016
3	Thalidomide (Thalomid)FDA Link 10/2021 - 01/2019
3	Agammaglobulinaemia Tyrosine KinaseIBA 10/2018 - 08/2014
3	InterleukinsIBA 10/2015 - 04/2014
2	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2023
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 01/2023
2	CytokinesIBA 11/2017 - 09/2011
1	vinyltriethoxysilane (VTES)IBA 11/2022
1	Proteasome InhibitorsIBA 01/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	pomalidomideIBA 01/2021
1	carboxyl radical (COO-)IBA 01/2021
1	Neutralizing AntibodiesIBA 11/2017
1	CholesterolIBA 10/2015
1	HepcidinsIBA 10/2015
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	ErbB Receptors (EGF Receptor)IBA 04/2014
1	ChemokinesIBA 09/2011
1	PlatinumIBA 09/2011

Therapy/Procedure

10	Therapeutics 12/2023 - 08/2014
4	Stem Cell Transplantation 11/2022 - 01/2019
2	Transplantation 11/2021 - 01/2021
1	Drug Therapy (Chemotherapy) 11/2021